A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York AvenueBox 314
New York, NY 10065
Phone: (646) 962-9476